SCHEMBL5029189

SCHEMBL5029189

O=C1CCC(=O)N1N(C(=O)O)c1cccnc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
GAA P10253 2/20 0.40
TSHR P16473 2/20 0.40
KCNA5 P22460 1/20 0.39
ALDH1A1 P00352 2/20 0.39
APP P05067 1/20 0.39
HCAR3 P49019 1/20 0.39
HCAR2 Q8TDS4 1/20 0.39
HTT P42858 1/20 0.38
CYP3A4 P08684 3/20 0.36
KDM4E B2RXH2 3/20 0.36
NOTUM Q6P988 1/20 0.36
LMNA P02545 1/20 0.36
NAPRT Q6XQN6 1/20 0.36
THRB P10828 1/20 0.35
THPO P40225 1/20 0.35
MEN1 O00255 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11711601 0.82 NPSR1 (0.39) GAAALDH1A1HTTKMT2ANPSR1
SCHEMBL16398787 0.71 GAA (0.50) GAATSHRKCNA5ALDH1A1APP
SCHEMBL28334865 0.69 GAA (0.44) GAATSHRKCNA5ALDH1A1APP
SCHEMBL9003057 0.69 NOTUM (0.43) GAATSHRALDH1A1HTTCYP3A4
SCHEMBL4433003 0.69 KMT2A (0.44) GAAALDH1A1HTTCYP3A4KDM4E
SCHEMBL5517164 0.68 GAA (0.47) L3MBTL1GAATSHRKCNA5ALDH1A1
SCHEMBL30518664 0.68 GAA (0.47) L3MBTL1GAATSHRKCNA5ALDH1A1
SCHEMBL965251 0.68 NOTUM (0.51) GAATSHRKCNA5ALDH1A1APP
SCHEMBL14882112 0.67 CHRM3 (0.51) GAATSHRKCNA5ALDH1A1APP
SCHEMBL18271274 0.67 ENPP2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10017481-B2 Conformationally constrained, fully synthetic macrocyclic compounds POLYPHOR AG (CH) 2018-07-10 US disclosed
US-20150051183-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS POLYPHOR AG (CH) 2015-02-19 US disclosed
EP-1919892-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2008-05-14 EP disclosed
WO-2007027527-A2 ISOINDOLE-IMIDE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORPORATION (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10017481-B2 Conformationally constrained, fully synthetic macrocyclic compounds CTSE, CTSB, CTSS L3MBTL1 1546/4885GAA 2400/4885TSHR 28/4885
US-20150051183-A1 CONFORMATIONALLY CONSTRAINED, FULLY SYNTHETIC MACROCYCLIC COMPOUNDS CTSE, CTSB, CTSS L3MBTL1 1546/4885GAA 2400/4885TSHR 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.